Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bacterial DNA replication machinery**, often called the *replisome*, comprises multiple proteins and enzymatic activities responsible for faithfully duplicating the circular chromosome before cell division. Key components include **DNA polymerase III**, which synthesizes new strands; **helicases**, which unwind double-stranded DNA; **primases**, which synthesize RNA primers; **ligases**, which seal nicks between Okazaki fragments on the lagging strand; and **topoisomerases/gyrases**, which relieve torsional strain during unwinding[1][2][4]. Replication initiates at a single origin site (*oriC*), proceeds bidirectionally around the chromosome at high speed (~1000 nucleotides/sec), and involves tightly coordinated action among all these factors. Because these proteins are essential for bacterial viability—and sufficiently distinct from their eukaryotic counterparts—they represent prime targets for antibiotic development. However, since “DNA replication in bacteria” describes an entire pathway/process rather than one discrete molecular entity, it should be mapped more specifically when possible—for example by focusing on “DNA polymerase III” or “bacterial type II topoisomerase” as canonical drug targets[6][8].
Drugs act by: - Inhibiting topoisomerases/gyrases required for relieving supercoiling during unwinding[1] - Preventing proper fork progression leads to double-strand breaks and cell death. - Example mechanism for quinolones. - Inhibiting other essential enzymes such as primase or ligase disrupts initiation/elongation steps. - Some experimental compounds directly inhibit the assembly/function of the replisome.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA replication machinery in bacteria (None standardized; sometimes referred to as "bacterial replisome" or "prokaryotic DNA replication complex," but no universal abbreviation.).